Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axis.
Wang B, Jiang B, Du L, Chen W, Zhang Q, Chen W, Ding M, Cao W, Gao J, Deng Y, Fu Y, Li Y, Xiao Y, Diao W, Guo H.
Wang B, et al. Among authors: du l.
Oncoimmunology. 2023 Nov 20;12(1):2279800. doi: 10.1080/2162402X.2023.2279800. eCollection 2023.
Oncoimmunology. 2023.
PMID: 38264343
Free PMC article.